CHESTERFIELD, Mo.--(BUSINESS WIRE)--With orphan drug development accelerating at an increasing rate, evidenced by a 64 percent increase and the number of orphan drugs designated by the FDA between 2005 and 2009, Centric Health Resources, Inc. presents its Third Annual Ultra Orphan Conference: “Emerging Commercialization Strategies for Addressing the Needs of Ultra-Orphan Patients – Maximize Product Launch and Extend Product Life Cycle One Patient at a Time,” September 27-29, 2010, The Westin Hotel, St. Louis, Mo.
